The Vitamin IV Boom: High Hopes, Low Evidence, Real Risks
Massachusetts medspas are riding a boom in vitamin IV infusions marketed for immunity and performance, with prices often between $200 and $600. IV drips deliver nutrients directly into the bloodstream, but evidence of benefit for healthy adults is limited and regulatory oversight is inconsistent. Medical experts warn of risks like infections, electrolyte imbalances, and fluid overload, advising that IV therapy should not replace vaccines or healthy habits.